![](/img/cover-not-exists.png)
FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer
Moore, Kathleen N, Vergote, Ignace, Oaknin, Ana, Colombo, Nicoletta, Banerjee, Susana, Oza, Amit, Pautier, Patricia, Malek, Karim, Birrer, Michael JLanguage:
english
Journal:
Future Oncology
DOI:
10.2217/fon-2017-0646
Date:
February, 2018
File:
PDF, 3.59 MB
english, 2018